FACULTY
Alexis A. Lizarraga MD, MS
Associate Professor
Neuromuscular Division
Department of Neurology
University of Rochester School of Medicine & Dentistry
Rochester, NY
Sabrina W. Yum, MD
Professor of Clinical Neurology and Pediatrics
Perelman School of Medicine at the University of Pennsylvania
Interim Director, Neuromuscular Program
Program Director, Neuromuscular Fellowship and Education
Children’s Hospital of Philadelphia
Philadelphia, PA
PROGRAM OVERVIEW
This enduring activity is designed to improve health care professionals’ ability to assess current and investigational therapies to manage generalized myasthenia gravis (gMG); enhance their understanding of the mechanism of FcRn antagonists; evaluate the burden of gMG in pregnant and pediatric populations; improve their use of current guidelines for evaluation and management in these populations; and increase their awareness of current clinical trials for these individuals.
TARGET AUDIENCE
This activity is designed to meet the educational needs of adult and pediatric neurologists and fellows; advanced care practitioners (eg, NPs, PharmD/RPh, and PAs); and other healthcare professionals who help manage people with gMG.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Assess the therapeutic developments for the management of myasthenia gravis, including the unique mechanism of FcRn antagonists.
- Evaluate the burden of gMG in pregnant women, as well as current guidelines for care and challenges in management.
- Summarize best practices in the evaluation, guideline-informed treatment, and consideration of ongoing clinical trials in pediatric patients with gMG.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.25 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Alexis A. Lizarraga, MD, MS | Receives consulting fee from Alexion Pharmaceuticals and Argenx USA |
| Sabrina W. Yum, MD | Site principal investigator (PI) for Inherited Neuropathies Consortium, a site PI or subinvestigator for several industry-sponsored trials in rheumatologic diseases and a consultant for Passage Bio |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Dominique Barton, RN, BSN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Deborah Gordon, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group has nothing to disclose.
- Felecia Beachum, Sr. Program Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to the live event at [email protected]
RELEASED DATE: November 27, 2024
EXPIRATION DATE: November 27, 2025
Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
